Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response.

Authors :: Martin Huertas R
Fernández Abad M
Corral de la Fuente E
Serrano Domingo JJ
Martínez Jáñez N
Source :: The breast journal [Breast J] 2020 Apr; Vol. 26 (4), pp. 800-802. Date of Electronic Publication: 2019 Sep 29.
Publication Year :: 2020

Subjects :: Antineoplastic Combined Chemotherapy Protocols therapeutic use
Capecitabine adverse effects
Female
Fluorouracil
Humans
Lapatinib
Neoplasm Recurrence, Local drug therapy
Receptor, ErbB-2
Trastuzumab
Treatment Outcome
Breast Neoplasms drug therapy
Inflammatory Breast Neoplasms drug therapy

Full Text Access

Tools